Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
First-in-Human Phase I Study of Pictilisib (GDC-0941), a Potent Pan–Class I Phosphatidylinositol-3-Kinase (PI3K) Inhibitor, in Patients with Advanced Solid Tumors
PaperCitations, authors & open-access status
First-in-Human Phase I Study of Pictilisib (GDC-0941), a Potent Pan–Class I Phosphatidylinositol-3-Kinase (PI3K) Inhibitor, in Patients with Advanced Solid Tumors is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 362 citations, 2014 year and bronze oa status.
362
Citations
2014
Year
bronze
OA Status